Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 11, Issue 14
|
pp. 5035–5057
Overexpression of KLF5 is associated with poor survival and G1/S progression in pancreatic cancer
Back to article
Figure 5
(5 of 9)
−
100%
+
Figure 5.
KLF5-targeted microRNAs in the pancreatic cancer pathway.
In the pancreatic cancer pathway extracted from the KEGG PATHWAY database (
http://www.genome.jp/kegg/pathway.html
), 12 microRNAs activated by KLF5 inhibit Smad4, p53, p16 and BRCA2.
